Shou-Jen Lan

Shou-Jen Lan

Auto-generated profile, based on publicly available information

Shou-Jen Lan

Department of Health Care Administration, Asia University, Taichung, Taiwan

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1994 in Bulletin of Environmental Contamination and Toxicology
Verified
Journal Article
Closed access
PDF file
YYY. -Y. Yen
Y. -Y. Yen
SLS. -J. Lan
S. -J. Lan
CYChun-Yuh Yang
Chun-Yuh Yang
HWH. -H. Wang
H. -H. Wang
CCC. -N. Chen
C. -N. Chen
CHC. -C. Hsieh
C. -C. Hsieh

1 January 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
CSChih-Pei Su
Chih-Pei Su
JWJr-Hau Wu
Jr-Hau Wu
MYMei-Chueh Yang
Mei-Chueh Yang
CLChing-Hui Liao
Ching-Hui Liao
HHHsiu-Ying Hsu
Hsiu-Ying Hsu
Yan-Ren LinYan-Ren Lin
Yan-Ren Lin
The outcome of patients suffering from out-of-hospital cardiac arrest (OHCA) is very poor, and postresuscitation comorbidities increase long-term mortality. This study aims to analyze new-onset postresuscitation comorbidities in patients who survived from OHCA for over one year. The Taiwan National Health Insurance (NHI) Database was used in this study. Study and comparison groups were created to analyze the risk of suffering from new-onset postresuscitation comorbidities from 2011 to 2012 (until December 31, 2013). The study group included 1,346 long-term OHCA survivors; the comparison group consisted of 4,038 matched non-OHCA patients. Demographics, patient characteristics, and risk of suffering comorbidities (using Cox proportional hazards models) were analyzed. We found that urinary tract infections (n=225, 16.72%), pneumonia (n=206, 15.30%), septicemia (n=184, 13.67%), heart failure (n=111, 8.25%) gastrointestinal hemorrhage (n=108, 8.02%), epilepsy or recurrent seizures (n=98, 7.28%), and chronic kidney disease (n=62, 4.61%) were the most common comorbidities. Furthermore, OHCA survivors were at much higher risk (than comparison patients) of experiencing epilepsy or recurrent seizures (HR = 20.83; 95% CI: 12.24–35.43), septicemia (HR = 8.98; 95% CI: 6.84–11.79), pneumonia (HR = 5.82; 95% CI: 4.66–7.26), and heart failure (HR = 4.88; 95% CI: 3.65–6.53). Most importantly, most comorbidities occurred within the first half year after OHCA.

2 June 2015 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
SCShin-Lin Chiu
Shin-Lin Chiu
CCChiao-Lee Chu
Chiao-Lee Chu
CMChih-Hsin Muo
Chih-Hsin Muo
CCChiu-Liang Chen
Chiu-Liang Chen
SLShou-Jen Lan
Shou-Jen Lan
Medical care in Taiwan is well known for its low cost, high efficiency, high quality, excellent medical accessibility, and high equity. We investigate the trends in medication expenditures for glaucoma from 1997 to 2010. The results show that higher medical expenditures were incurred by patients who were aged ≥40 years, male patients, and patients in the highest salary population whereas lower medical expenditures were incurred by blue-collar workers. The medications with the most significant increases in expenditure were prostaglandin analogs (PGAs),α-agonists, and fixed combinations, whereas the medications with the most significant decreases in expenditure wereβ-blockers and cholinergic agonists. The number of trabeculectomies shows two downward break points in 1999 and 2000 when PGAs were listed and were reimbursed. These results suggest socioeconomic disparities in glaucoma care, as well as understanding of the changes in the expenditure of glaucoma medications under such universal health insurance coverage system.